Abstract
IntroductionAbout 25% of patients with COVID-19 develop acute respiratory distress syndrome (ARDS) associated with a high release of pro-inflammatory cytokines such as interleukin-6 (IL-6). The aim of the SARICOR study...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have